Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.737
AS - Asia 8.445
EU - Europa 6.635
SA - Sud America 1.066
Continente sconosciuto - Info sul continente non disponibili 925
AF - Africa 196
OC - Oceania 44
Totale 32.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.888
SG - Singapore 3.262
CN - Cina 1.839
IT - Italia 1.222
DE - Germania 1.084
HK - Hong Kong 1.034
RU - Federazione Russa 932
VN - Vietnam 888
SE - Svezia 865
BR - Brasile 784
CA - Canada 719
IE - Irlanda 666
UA - Ucraina 561
GB - Regno Unito 376
FR - Francia 295
IN - India 266
BD - Bangladesh 194
KR - Corea 185
FI - Finlandia 170
AT - Austria 117
ID - Indonesia 108
AR - Argentina 107
TR - Turchia 97
JP - Giappone 88
IQ - Iraq 75
DK - Danimarca 69
ZA - Sudafrica 69
MX - Messico 68
NL - Olanda 57
ES - Italia 53
PK - Pakistan 53
PL - Polonia 47
MY - Malesia 46
PH - Filippine 43
SA - Arabia Saudita 42
CO - Colombia 36
EC - Ecuador 35
VE - Venezuela 32
IR - Iran 27
BE - Belgio 23
CL - Cile 22
AU - Australia 21
EG - Egitto 20
PY - Paraguay 20
UZ - Uzbekistan 20
MA - Marocco 19
NZ - Nuova Zelanda 19
ET - Etiopia 18
EU - Europa 18
KZ - Kazakistan 18
TH - Thailandia 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
KE - Kenya 17
LT - Lituania 17
JO - Giordania 16
NP - Nepal 16
CH - Svizzera 14
UY - Uruguay 14
AZ - Azerbaigian 11
OM - Oman 11
IL - Israele 10
CZ - Repubblica Ceca 9
JM - Giamaica 9
PE - Perù 9
PS - Palestinian Territory 9
TT - Trinidad e Tobago 9
AL - Albania 7
BG - Bulgaria 7
BH - Bahrain 7
CR - Costa Rica 7
HN - Honduras 7
KG - Kirghizistan 7
LB - Libano 7
AO - Angola 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
NG - Nigeria 6
PA - Panama 6
RS - Serbia 6
TW - Taiwan 6
DZ - Algeria 5
GE - Georgia 5
HR - Croazia 5
GT - Guatemala 4
MD - Moldavia 4
RO - Romania 4
SN - Senegal 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
KW - Kuwait 3
MM - Myanmar 3
NI - Nicaragua 3
NO - Norvegia 3
PR - Porto Rico 3
PT - Portogallo 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
Totale 31.102
Salva come PNG Salva come JPEG
Città #
Singapore 2.045
Ann Arbor 1.879
Ashburn 1.168
Hong Kong 988
San Jose 950
Woodbridge 820
Chandler 689
Dublin 644
Jacksonville 551
Houston 543
Toronto 495
Frankfurt am Main 485
Milan 477
Fairfield 456
Wilmington 449
Dearborn 424
New York 352
Dallas 346
Santa Clara 304
Beijing 272
Council Bluffs 256
Ho Chi Minh City 249
Los Angeles 249
Princeton 246
Boardman 218
Chicago 218
The Dalles 197
Hanoi 187
Seattle 183
Nanjing 178
Cambridge 138
Shanghai 136
Seoul 130
Hefei 119
Vienna 111
Lauterbourg 108
Rome 104
Buffalo 93
Lachine 89
Dong Ket 78
Guangzhou 78
Columbus 74
Jakarta 74
Moscow 74
Altamura 73
Lawrence 73
Orem 67
Nanchang 59
São Paulo 58
Munich 54
Helsinki 51
Fremont 45
Shenyang 44
Andover 42
Tokyo 41
Grafing 40
Jinan 40
Brooklyn 38
Zhengzhou 37
Da Nang 36
Jiaxing 36
Johannesburg 34
Atlanta 33
Denver 33
Montreal 33
Nürnberg 33
Phoenix 33
San Diego 33
Springfield 33
Tianjin 32
Baghdad 31
Changsha 31
Chennai 31
Rio de Janeiro 30
London 29
Pune 29
Ottawa 27
Falls Church 26
Daejeon 24
Haiphong 24
Hangzhou 24
Kunming 24
Ankara 23
Mountain View 23
Philadelphia 23
Warsaw 23
Hebei 22
Istanbul 22
Nuremberg 22
Sacramento 22
Basingstoke 21
Boston 21
Brussels 21
Figino 20
San Francisco 20
Stockholm 20
Tashkent 20
Dhaka 19
Turku 19
Addis Ababa 18
Totale 19.764
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 510
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 502
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 473
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 446
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 442
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 439
Age-related changes in the function and structure of the peripheral sensory pathway in mice 425
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 422
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 418
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 408
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 402
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 389
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 363
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 344
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 334
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 331
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 330
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 330
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 323
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 320
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 320
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 318
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 312
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 311
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 308
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 303
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 301
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 301
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 301
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 300
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 300
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 299
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 293
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 292
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 289
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 286
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 282
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 276
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 273
Effect of proteasome inhibition on the central and peripheral nervous system 273
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 272
Multimodal experimental approach to the study of human neurological diseases 272
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 266
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 263
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 262
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 261
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 261
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 260
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 259
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 258
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 257
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 256
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 254
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 254
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 253
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 252
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 252
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 251
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 251
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 250
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 250
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 250
Lipoplatin tm: a less neurotoxic formulation of cisplatin 250
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 249
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 248
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 246
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 245
Granulocytes in actively induced Lewis rat EAE 243
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 242
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 239
Erythropoietin both protects from and reverses experimental diabetic neuropathy 238
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats 238
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 237
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 237
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 237
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 232
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 231
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 228
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 225
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 224
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 222
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 220
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 220
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 218
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models 214
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 213
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 212
Regression of diabetic complications by islet transplantation in the rat 212
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 211
Biodistrubution and toxicology of two PFCs intravenously injected in rats 209
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 209
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 208
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 208
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 207
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 203
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 202
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 202
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 196
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 195
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib 193
Totale 28.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.314 0 139 137 127 96 142 65 76 57 116 102 257
2022/20232.631 297 726 232 255 192 426 34 137 210 30 51 41
2023/20242.006 64 61 78 64 274 525 348 89 99 40 23 341
2024/20254.437 280 601 354 206 345 118 203 166 470 609 406 679
2025/202611.688 1.130 676 905 918 1.166 739 1.865 606 996 998 781 908
2026/2027725 445 280 0 0 0 0 0 0 0 0 0 0
Totale 32.048